These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16643584)

  • 1. Zonisamide prophylaxis in refractory pediatric headache.
    Pakalnis A; Kring D
    Headache; 2006 May; 46(5):804-7. PubMed ID: 16643584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zonisamide for migraine prophylaxis in refractory patients.
    Ashkenazi A; Benlifer A; Korenblit J; Silberstein SD
    Cephalalgia; 2006 Oct; 26(10):1199-202. PubMed ID: 16961786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zonisamide monotherapy for epilepsy in children and young adults.
    Wilfong AA
    Pediatr Neurol; 2005 Feb; 32(2):77-80. PubMed ID: 15664764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term use of zonisamide in refractory childhood-onset epilepsy.
    Kluger G; Zsoter A; Holthausen H
    Eur J Paediatr Neurol; 2008 Jan; 12(1):19-23. PubMed ID: 17574461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zonisamide versus topiramate in migraine prophylaxis: a double-blind randomized clinical trial.
    Mohammadianinejad SE; Abbasi V; Sajedi SA; Majdinasab N; Abdollahi F; Hajmanouchehri R; Faraji A
    Clin Neuropharmacol; 2011; 34(4):174-7. PubMed ID: 21738025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy and safety of monotherapy and adjunctive therapy with zonisamide.
    Tosches WA; Tisdell J
    Epilepsy Behav; 2006 May; 8(3):522-6. PubMed ID: 16542880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of zonisamide in patients with chronic pain or epilepsy refractory to other treatments: a retrospective, open label, uncontrolled study in a VA hospital.
    Hasegawa H
    Curr Med Res Opin; 2004 May; 20(5):577-80. PubMed ID: 15140322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of zonisamide in pediatric patients.
    Santos CC; Brotherton T
    Pediatr Neurol; 2005 Jul; 33(1):12-4. PubMed ID: 15876518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long-term follow-up of zonisamide monotherapy.
    Fukushima K; Seino M
    Epilepsia; 2006 Nov; 47(11):1860-4. PubMed ID: 17116025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy.
    Kothare SV; Kaleyias J; Mostofi N; Valencia I; Melvin JJ; Hobdell E; Khurana DS; Legido A
    Pediatr Neurol; 2006 May; 34(5):351-4. PubMed ID: 16647993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonisamide for migraine prophylaxis in patients refractory to topiramate.
    Bermejo PE; Dorado R
    Clin Neuropharmacol; 2009; 32(2):103-6. PubMed ID: 18978487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential efficacy of zonisamide in refractory juvenile myoclonic epilepsy: retrospective evidence from an Irish compassionate-use case series.
    O'Rourke D; Flynn C; White M; Doherty C; Delanty N
    Ir Med J; 2007 Apr; 100(4):431-3. PubMed ID: 17566478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zonisamide for migraine prophylaxis in topiramate-intolerant patients: an observational study.
    Villani V; Ciuffoli A; Prosperini L; Sette G
    Headache; 2011 Feb; 51(2):287-91. PubMed ID: 21284610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is adjunctive open-label zonisamide effective for bipolar disorder?
    Ghaemi SN; Shirzadi AA; Klugman J; Berv DA; Pardo TB; Filkowski MM
    J Affect Disord; 2008 Jan; 105(1-3):311-4. PubMed ID: 17586053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy.
    Marinas A; Villanueva V; Giráldez BG; Molins A; Salas-Puig J; Serratosa JM
    Epileptic Disord; 2009 Mar; 11(1):61-6. PubMed ID: 19264587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zonisamide: new drug. No advantage in refractory partial epilepsy.
    Prescrire Int; 2007 Jun; 16(89):95-7. PubMed ID: 17582922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of zonisamide in Lennox-Gastaut syndrome: Korean multicentric experience.
    You SJ; Kang HC; Kim HD; Lee HS; Ko TS
    Brain Dev; 2008 Apr; 30(4):287-90. PubMed ID: 17959327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mexiletine for refractory chronic daily headache: a report of nine cases.
    Marmura MJ; Passero FC; Young WB
    Headache; 2008; 48(10):1506-10. PubMed ID: 18793209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.